Literature DB >> 17631598

Advances in the treatment of hematological malignancies: current treatment approaches in multiple myeloma.

H Ludwig1, K Strasser-Weippl, M Schreder, N Zojer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17631598     DOI： 10.1093/annonc/mdm296

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

Review 1.  Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma.

Authors:  Sean T Duggan; Gillian M Keating
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

2.  Hodgkin's lymphoma developed after autologous stem cell transplantation for multiple myeloma: transformation or coincidental appearance?

Authors:  Istvan Kulcsar; Antonia Szanto; Laszlo Varoczy; Gabor Mehes; Margit Zeher
Journal:  Pathol Oncol Res       Date:  2011-11-24       Impact factor: 3.201

Review 3.  Lenalidomide: a review of its use in the treatment of relapsed or refractory multiple myeloma.

Authors:  Lesley J Scott; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2011-03-26       Impact factor: 9.546

4.  Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma.

Authors:  H G Kopp; S Yildirim; K C Weisel; L Kanz; W Vogel
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-22       Impact factor: 4.553

Review 5.  Molecular targeting of liposomal nanoparticles to tumor microenvironment.

Authors:  Gang Zhao; B Leticia Rodriguez
Journal:  Int J Nanomedicine       Date:  2012-12-28

6.  Facial Swelling as a Primary Manifestation of Multiple Myeloma.

Authors:  Anju E Thomas; Seema Kurup; Renju Jose; Cristalle Soman
Journal:  Case Rep Dent       Date:  2015-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.